FDA Accepts Sanofi New Drug Application for Once-Daily Fixed-Ratio Combination of Insulin Glargine and Lixisenatide
Go back to FDA Accepts Sanofi New Drug Application for Once-Daily Fixed-Ratio Combination of Insulin Glargine and Lixisenatide| BANCO SANTANDER S.A. (NYSE: SAN) | Delayed: 14.26 +0.09 (0.64%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.17 | 52 Week High | $5.58 | |||
| Open | $14.30 | 52 Week Low | $3.60 | |||
| Day High | $14.35 | P/E | N/A | |||
| Day Low | $14.19 | EPS | $0.00 | |||
| Volume | 12,571,603 | |||||
| SANOFI (NASDAQ: SNY) | Delayed: 45.45 -0.38 (0.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $45.83 | 52 Week High | $44.76 | |||
| Open | $45.65 | 52 Week Low | $36.81 | |||
| Day High | $45.74 | P/E | N/A | |||
| Day Low | $45.06 | EPS | $0.00 | |||
| Volume | 1,059,072 | |||||

